Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Sensipar: Cipla Challenges Legality of Amgen/Teva Patent Settlement

Related Content

Launch Abbreviated: Teva Halts US Generic Sensipar Sales After Patent Deal With Amgen

Jan 03 2019

Sensipar Generics: US Court Victory, FDA Approval Position Piramal For Launch

Aug 08 2018

Related Companies

Amgen, Inc.

Teva Pharmaceutical Industries Ltd.

Cipla Limited

Viatris Inc.

Torrent Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Amneal Pharmaceuticals, Inc.

Zydus Pharmaceuticals (USA) Inc.

Additional Topics

United States Generic Drugs Intellectual Property Legal Issues Commercial Renal BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window